CCMP Capital

Founded in 1984 as Chemical Venture Partners, the firm served as the private equity arm of Chemical Bank. Over the decades, it evolved through major bank mergers, operating as Chase Capital Partners and later JP Morgan Partners. In July 2006, the investment professionals separated from JPMorgan Chase to form CCMP Capital, an acronym reflecting its heritage (Chemical, Chase, and JP Morgan Partners). At the time of the spin-out, the venture capital team formed a separate entity called Panorama Capital.

The firm specializes in mid-market leveraged buyouts and growth equity investments. Since its inception, CCMP has invested approximately $12 billion in these transaction types. While historically maintaining a global presence with offices in London, Hong Kong, and Tokyo, its regional units have occasionally transitioned into independent firms, such as the 2008 separation of its Asian arm into Unitas Capital.

In its recent history, CCMP has been active in sectors ranging from consumer retail and healthcare to industrials. Notable activities include the $900 million sale of Medpace to Cinven in 2014 and the acquisition of Badger Sportswear in 2016. The firm successfully closed CCMP Capital Investors II in 2007 with $3.4 billion in institutional commitments.